Oraqix and Macroangiopathy (expanded source)


Summary

There is no Macroangiopathy reported by people who take Oraqix yet. This review analyzes which people have Macroangiopathy with Oraqix. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Oraqix and have Macroangiopathy, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 13, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Macroangiopathy when taking Oraqix?

Expand the study to include all drugs with the same ingredients

Macroangiopathy and drugs with ingredients of lidocaine; prilocaine.

Limit the study to reports from FDA only

Macroangiopathy and Oraqix from FDA reports

Oraqix

Oraqix has active ingredients of lidocaine; prilocaine. (latest outcomes from Oraqix 30 users)

Macroangiopathy

Macroangiopathy (a disease of the large blood vessels in which fat and blood clots build up and stick to the vessel walls, blocking the flow of blood) has been reported by people with high blood pressure, breast cancer, stroke, type 2 diabetes, prostate cancer (latest reports from 34 Macroangiopathy patients).

Browse all side effects of Oraqix

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Macroangiopathy

Macroangiopathy

Could your condition cause Macroangiopathy

Macroangiopathy

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Oraqix and have Macroangiopathy.